Candel Therapeutics's market cap is currently $543.05M. The company's EPS TTM is $-1.741; its P/E ratio is ―; Candel Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 125.00K	$ 125.00K	$ 125.00K	$ 125.00K
Gross Profit	$ -23.98M	$ -862.00K	$ -107.00K	$ 125.00K	$ -6.48M
Operating Income	$ -38.39M	$ -34.72M	$ -25.73M	$ -13.81M	$ -9.04M
EBITDA	$ -37.43M	$ -17.32M	$ -25.49M	$ -13.72M	$ -8.20M
Net Income	$ -37.94M	$ -2.87M	$ -36.18M	$ -22.17M	$ -8.01M
Balance Sheet
Cash & Short-Term Investments	$ 35.41M	$ 70.06M	$ 82.64M	$ 35.05M	$ 45.06M
Total Assets	$ 41.20M	$ 77.69M	$ 89.20M	$ 38.28M	$ 45.90M
Total Debt	$ 22.76M	$ 22.80M	$ 560.00K	$ 946.00K	$ 420.00K
Net Debt	$ -12.65M	$ -47.26M	$ -82.08M	$ -34.11M	$ -4.76M
Total Liabilities	$ 28.46M	$ 29.98M	$ 25.07M	$ 61.84M	$ 53.94M
Stockholders' Equity	$ 12.74M	$ -99.09M	$ 64.14M	$ -23.56M	$ -8.04M
Cash Flow
Free Cash Flow	$ -34.70M	$ -32.72M	$ -24.05M	$ -10.55M	$ -5.34M
Operating Cash Flow	$ -34.24M	$ -31.42M	$ -22.22M	$ -9.07M	$ -5.18M
Investing Cash Flow	$ -280.00K	$ -1.30M	$ -1.83M	$ 38.45M	$ -35.74M
Financing Cash Flow	$ -121.00K	$ 19.97M	$ 71.80M	$ 490.00K	$ 21.98M

Currency in USD

Candel Therapeutics Earnings and Revenue History

Income Statement >

Candel Therapeutics Debt to Assets

Balance Sheet >

Candel Therapeutics Cash Flow

Cash Flow >

Candel Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing